Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Researchers at the Center of Excellence for Myelin Repair, a part of Mount Sinai, say gut bacteria produces compounds that have been seen to affect the myelin content in mice and cause social...
People with progressive MS make up around half of the UK’s 100,000 MS population, but according to a new report by the MS Trust growing pressures on NHS services mean they get much less support from...
Tysabri didn't slow disability progression in patients with secondary progressive multiple sclerosis (SPMS). The ASCEND trial missed its primary endpoint of reducing progression as measured by a...
A new database containing nearly 2,500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators. This is just one...
A discussion organised by the Consortium of Multiple Sclerosis Centres (CMSC) has considered the role of vitamin D in multiple sclerosis (MS). Researchers concluded that, while evidence is only...
A test that measures olfactory dysfunction is an easy method of identifying patients with paediatric-onset multiple sclerosis (POMS) who are at increased risk of cognitive impairment, according to a...
Scientists are set to revolutionise medicine by sampling the DNA of two million people to develop new drugs, the Daily Mail reports. The British-led project – which may eventually cost around £1.4bn...
New data demonstrates increased disease activity in patients with multiple sclerosis (MS) and a history of food allergies, according to a study presented at the 68th Annual Meeting of the American...
Stopping smoking could help to slow brain volume loss in patients with multiple sclerosis (MS), according to data presented at the 2016 annual meeting of the American Academy of Neurology (AAN)....
Patients with multiple sclerosis (MS) taking Ocrelizumab are more likely to achieve no evidence of disease activity (NEDA) than those taking beta interferon, researchers from the pivotal OPERA I and...

Pages